Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbar radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

Neuropathic pain is caused by disorders of, or damage to, the nervous system. The affected nerves can induce the sensation of pain in the brain. Neuropathic pain is often associated with the ...

A trial with XG005 met it's primary and secondary endpoints, demonstrating a statistically significant reduction in post-surgery pain compared to placebo.

Recently, evidence from experimental human pain research has indicated that in many of these patients pain processing in the central nervous system is abnormal and mimics that seen in neuropathic pain ...

Biohaven Ltd. (NYSE: BHVN) today announced that Vlad Coric, M.D., Chairman and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, announced today that it has received clearance ...

Neuropathic ... the pain and temperature sensory fibers as they cross the midline. Their loss in the upper extremity, with intact position sense and motor function, is often the first clinical ...

The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...

New use of gabapentin (Neurontin) was not associated with greater risk of falls in older adults with neuropathy or ...

In a world where health supplements are increasingly prevalent, finding a product that genuinely supports your well-being can ...

KLS-2031 is under clinical development by Kolon Life Science and currently in Phase II for Radiculopathy. According to GlobalData, Phase II drugs for Radiculopathy does not have sufficient historical ...